Amgen
AMGN
Amgen (AMGN) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Equal-Weight | $430.00 from $435.00 | Oct 12, 2026 |
| BMO Capital | Maintained | Market Perform | $415.00 from $450.00 | Oct 12, 2026 |
| UBS | Maintained | Buy | $470.00 from $430.00 | Oct 9, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $440.00 from $400.00 | Oct 8, 2026 |
| RBC Capital | Maintained | Outperform | $430.00 from $400.00 | Oct 8, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $359.00 from $362.00 | Oct 7, 2026 |
| Truist Securities | Maintained | Hold | $380.00 from $362.00 | Oct 7, 2026 |
| Scotiabank | Maintained | Sector Outperform | $500.00 from $450.00 | Sep 29, 2026 |
| HSBC | Downgraded | Buy → Hold | $425.00 from $445.00 | Sep 10, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $400.00 | Sep 8, 2026 |
| BMO Capital | Downgraded | Outperform → Market Perform | $450.00 | Sep 8, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $435.00 from $400.00 | Sep 4, 2026 |
| Piper Sandler | Maintained | Overweight | $457.00 from $427.00 | Aug 20, 2026 |
| Argus Research | Maintained | Buy | $460.00 from $375.00 | Aug 19, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $400.00 from $350.00 | Aug 18, 2026 |
| Mizuho | Maintained | Neutral | $352.00 from $303.00 | Aug 18, 2026 |
| Barclays | Maintained | Equal-Weight | $380.00 from $360.00 | Aug 14, 2026 |
| Guggenheim | Maintained | Neutral | $388.00 from $343.00 | Aug 10, 2026 |
| Citigroup | Maintained | Neutral | $405.00 from $345.00 | Aug 7, 2026 |
| Bernstein | Maintained | Market Perform | $345.00 from $335.00 | Aug 6, 2026 |
Frequently asked questions
What is the latest analyst rating on AMGN?
On Oct 12, 2026, Wells Fargo maintained Amgen at Equal-Weight with a price target of $430.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
